UNAUDITED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2012	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2011
Sales
External customers	$ 50,466,339	$ 41,664,996	$ 97,693,800	$ 76,060,234
Related party	0	462	0	76,046
Total sales	50,466,339	41,665,458	97,693,800	76,136,280
Cost of sales
External customers	16,130,889	12,512,359	31,846,616	21,789,563
Related party	0	210	0	34,604
Cost of sales	16,130,889	12,512,569	31,846,616	21,824,167
Gross profit	34,335,450	29,152,889	65,847,184	54,312,113
Operating expenses
Selling expenses	4,165,242	3,038,143	8,991,349	5,488,056
General and administrative expenses	7,932,372	7,665,306	15,078,166	15,129,447
Research and development expenses	929,489	1,218,977	1,640,077	1,929,968
Income from operations	21,308,347	17,230,463	40,137,592	31,764,642
Other (income) / expenses
Equity in income of equity method investee	(451,891)	(463,688)	(1,474,303)	(734,082)
Change in fair value of derivative liabilities	(559,758)	(11,175,384)	(1,769,140)	(12,197,249)
Interest expense	157,635	2,300,601	766,198	3,981,523
Interest income	(765,717)	(269,594)	(1,309,112)	(439,725)
Other expenses, net	1,797	846,051	102,786	1,070,282
Total other income, net	(1,617,934)	(8,762,014)	(3,683,571)	(8,319,251)
Earnings before income tax expense	22,926,281	25,992,477	43,821,163	40,083,893
Income tax expense	3,333,616	5,317,249	6,510,331	9,580,465
Net income	19,592,665	20,675,228	37,310,832	30,503,428
Less: Net income attributable to the noncontrolling interest	6,753,894	4,075,523	11,514,755	7,594,748
Net income attributable to China Biologic Products, Inc.	12,838,771	16,599,705	25,796,077	22,908,680
Net income per share:
Basic	$ 0.5	$ 0.67	$ 1.00	$ 0.94
Diluted	$ 0.46	$ 0.28	$ 0.90	$ 0.53
Weighted average shares used in computation:
Basic	25,875,164	24,632,774	25,738,145	24,492,728
Diluted	26,627,160	26,738,279	26,581,824	26,802,683
Other Comprehensive income, net of nil income taxes
Foreign currency translation adjustment	136,178	2,699,426	1,313,135	3,825,840
Comprehensive income	19,728,843	23,374,654	38,623,967	34,329,268
Less: Comprehensive income attributable to the noncontrolling interest	6,750,933	4,526,465	11,766,768	8,314,296
Comprehensive income attributable to China Biologic Products, Inc.	$ 12,977,910	$ 18,848,189	$ 26,857,199	$ 26,014,972